Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterNo recent work listed

Xiaoqing Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4585-9372; OpenAlex author ID A5078872209. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 2 papers

Papers 2

  1. A prognostic model based on tumor microenvironment-related lncRNAs predicts therapy response in pancreatic cancer. Last author DOI 10.1007/s10142-023-00964-x↗
  2. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing. Co-author DOI 10.1038/s41467-023-44126-w↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianzhong Lu · 1 shared paper, 2023 · strength 0.31
  2. Paul A. Stewart · 1 shared paper, 2023 · strength 0.14
  3. Michelle M. Maurin · 1 shared paper, 2023 · strength 0.14
  4. Barbara Ann Centeno · 1 shared paper, 2023 · strength 0.14
  5. Jason B. Fleming · 1 shared paper, 2023 · strength 0.14
  6. Karen M. Mann · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.